{"Symbol": "ANIX", "AssetType": "Common Stock", "Name": "Anixa Biosciences Inc", "Description": "Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company is headquartered in San Jose, California.", "CIK": "715446", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "3150 ALMADEN EXPRESSWAY, SAN JOSE, CA, UNITED STATES, 95118", "OfficialSite": "https://www.anixa.com", "FiscalYearEnd": "October", "LatestQuarter": "2025-10-31", "MarketCapitalization": "94130000", "EBITDA": "-13097416", "PERatio": "None", "PEGRatio": "None", "BookValue": "0.459", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-0.34", "RevenuePerShareTTM": "0", "ProfitMargin": "0", "OperatingMarginTTM": "0", "ReturnOnAssetsTTM": "-0.388", "ReturnOnEquityTTM": "-0.672", "RevenueTTM": "0", "GrossProfitTTM": "0", "DilutedEPSTTM": "-0.34", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0", "AnalystTargetPrice": "10.75", "AnalystRatingStrongBuy": "1", "AnalystRatingBuy": "3", "AnalystRatingHold": "0", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "481.54", "PriceToBookRatio": "6.21", "EVToRevenue": "368.98", "EVToEBITDA": "-8.76", "Beta": "0.489", "52WeekHigh": "5.46", "52WeekLow": "2.331", "50DayMovingAverage": "3.41", "200DayMovingAverage": "3.406", "SharesOutstanding": "33379500", "SharesFloat": "31572700", "PercentInsiders": "5.405", "PercentInstitutions": "16.374", "DividendDate": "None", "ExDividendDate": "None"}